Edarbyclor
NDC 60631-412, Azilsartan kamedoxomil and chlorthalidone, tablet, from Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals).
- Product NDC
- 60631-412
- Status
- Listed
- Labeler
- Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA202331
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60631-412 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AZILSARTAN KAMEDOXOMIL40 mg/1
- CHLORTHALIDONE12.5 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Blocker [EPC]; Angiotensin 2 Type 1 Receptor Antagonists [MoA]; Decreased Blood Pressure [PE]; Increased Diuresis [PE]; Thiazide-like Diuretic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60631-412-30 | 60631041230 | 30 TABLET in 1 BOTTLE (60631-412-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e60f795b-fce3-4361-aa03-f143451689d1NADAC price for package 60631041230
GET /v1/drugs/nadac/60631041230
Use it
Look up 60631-412 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60631-412 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60631-412. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.